The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Cetera Investment Advisers

Cetera Investment Advisers raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 24,049 shares of the medical device company’s stock after buying an additional 312 shares during the quarter. Cetera Investment Advisers’ holdings in Cooper Companies were worth $2,211,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. grew its holdings in Cooper Companies by 2.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock valued at $705,928,000 after buying an additional 155,233 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock worth $460,066,000 after purchasing an additional 74,501 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Cooper Companies by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after purchasing an additional 109,907 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after purchasing an additional 574,899 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock worth $324,466,000 after purchasing an additional 2,957,421 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $82.92 on Monday. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The stock has a market capitalization of $16.58 billion, a P/E ratio of 42.52, a PEG ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The business’s fifty day moving average price is $80.19 and its 200 day moving average price is $90.00.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

COO has been the topic of several analyst reports. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird decreased their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Finally, BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.